Scott Christopher Fahrenkrug
age ~61
from Minneapolis, MN
- Also known as:
-
- Scott C Fahrenkrug
- Scott C Fanrenkrug
- Scott C Christensen
- Sandy Fahrenkrug
- Scott G
- Phone and address:
- 3433 E 25Th St, Minneapolis, MN 55406
Scott Fahrenkrug Phones & Addresses
- 3433 E 25Th St, Minneapolis, MN 55406
- 2751 Hayes St NE, Minneapolis, MN 55418
- 1549 Arkwright St, Saint Paul, MN 55130
- 525 Laurel Ave, Saint Paul, MN 55102
- 744 Ashland Ave, Saint Paul, MN 55104
- 744 Ashland Ave #106, Saint Paul, MN 55104
- Lino Lakes, MN
- Fairfield, NE
- Harvard, NE
- Grand Forks, ND
Us Patents
-
Method For Producing A Transgenic Pig Using A Hyper-Methylated Transposon
view source -
US Patent:8309791, Nov 13, 2012
-
Filed:Jul 16, 2009
-
Appl. No.:12/504364
-
Inventors:Scott C. Fahrenkrug - Minneapolis MN, US
Daniel F. Carlson - Inver Grove Heights MN, US
Aron M. Geurts - New Berlin WI, US -
Assignee:Recombinectics, Inc. - Saint Paul MN
-
International Classification:A01K 67/027
C12N 15/00 -
US Classification:800 17, 800 25
-
Abstract:Transgenic artiodactyls are described as well as methods of making and using such artiodactyls.
-
Methods And Materials For Producing Transgenic Artiodactyls
view source -
US Patent:8518701, Aug 27, 2013
-
Filed:May 9, 2012
-
Appl. No.:13/467588
-
Inventors:Scott C. Fahrenkrug - Minneapolis MN, US
Daniel F. Carlson - Inner Grove Heights MN, US -
Assignee:Recombinetics, Inc. - Minneapolis MN
-
International Classification:C12N 5/16
C12N 5/07
C12N 15/63 -
US Classification:435455, 435347
-
Abstract:Swine animal models comprising a genomic disruption of an endogenous gene chosen from the group consisting of a Low-Density Lipoprotein Receptor gene LDLR, Duchene's Muscular Dystrophy (DMD) gene, and hairless gene (HR). Methods of preparing transfected cells useful for making a transgenic animal comprising exposing a first group of cells to a transfection agent and reseeding the group with additional cells that have not been exposed to the agent. The transgenic animals are useful for medical and scientific animal models of human diseases and conditions, as well as sources for cells, tissues, and biomaterials.
-
Using Cytosine Deaminases To Diminish Retroelement Transfer From Pigs To Humans
view source -
US Patent:20070033666, Feb 8, 2007
-
Filed:Jun 22, 2006
-
Appl. No.:11/472743
-
Inventors:Reuben Harris - St. Paul MN, US
Stefan Jonsson - Kopavogur, IS
Scott Fahrenkrug - Minneapolis MN, US
Rebecca Larue - Lauderdale MN, US -
International Classification:A01K 67/027
C12N 5/06 -
US Classification:800017000, 435325000
-
Abstract:Transgenic pigs that express one or more non-porcine cytosine deaminases are described as well as methods of making and using such pigs.
-
Using Cytosine Deaminases To Diminish Retroelement Transfer From Pigs To Humans
view source -
US Patent:20090049563, Feb 19, 2009
-
Filed:Oct 1, 2008
-
Appl. No.:12/243711
-
Inventors:REUBEN S. HARRIS - ST. PAUL MN, US
STEFAN R. JONSSON - KOPAVOGUR, IS
SCOTT C. FAHRENKRUG - MINNEAPOLIS MN, US
REBECCA ST. CLAIRE LARUE - LAUDERDALE MN, US -
Assignee:REGENTS OF THE UNIVERSITY OF MINNESOTA - SAINT PAUL MN
-
International Classification:A01K 67/027
-
US Classification:800 17
-
Abstract:Transgenic pigs that express one or more non-porcine cytosine deaminases are described as well as methods of making and using such pigs.
-
Plaice Dna Transposon System
view source -
US Patent:20100105140, Apr 29, 2010
-
Filed:Jul 16, 2009
-
Appl. No.:12/504286
-
Inventors:Scott C. Fahrenkrug - Minneapolis MN, US
Karl J. Clark - Rochester MN, US
Daniel F. Carlson - Inver Grove Heights MN, US
Michael J. Leaver - Stirling, GB -
International Classification:C12N 15/85
C12N 9/12
C07H 21/00
C12N 5/00 -
US Classification:435455, 435194, 536 232, 435325
-
Abstract:This document describes the Passport transposon system and methods of making and using the same.
-
Using Cytosine Deaminases To Diminish Retroelement Transfer From Pigs To Humans
view source -
US Patent:20100251395, Sep 30, 2010
-
Filed:Nov 20, 2009
-
Appl. No.:12/622886
-
Inventors:Reuben S. Harris - St. Paul MN, US
Stefan R. Jonsson - Kopavogur, IS
Scott C. Fahrenkrug - Minneapolis MN, US
Rebecca St. Claire Larue - Lauderdale MN, US -
International Classification:A01K 67/00
C12N 5/10 -
US Classification:800 17, 435325
-
Abstract:Transgenic pigs that express one or more non-porcine cytosine deaminases are described as well as methods of making and using such pigs.
-
Methods And Compositions For Targeted Gene Modification
view source -
US Patent:20110059160, Mar 10, 2011
-
Filed:Aug 26, 2010
-
Appl. No.:12/869232
-
Inventors:Jeffrey J. Essner - Ames IA, US
Hsin-Kai Liao - Ames IA, US
Scott C. Fahrenkrug - Minneapolis MN, US -
International Classification:A61K 9/127
C12N 15/87
C12N 5/10
A01K 67/02
C12N 9/12
A61K 38/45
A61P 43/00 -
US Classification:424450, 435455, 435325, 435366, 435419, 800 13, 435194, 424 945
-
Abstract:Disclosed herein are methods and compositions for gene targeting utilizing fusion molecules comprising a recombinase domain and a sequence-specific DNA-binding domain.
-
Methods And Materials For Producing Transgenic Artiodactyls
view source -
US Patent:20110197290, Aug 11, 2011
-
Filed:Feb 11, 2011
-
Appl. No.:13/025373
-
Inventors:Scott C. Fahrenkrug - Minneapolis MN, US
Daniel F. Carlson - Inver Grove Heights MN, US -
International Classification:A01K 67/027
C12N 5/07
C12N 5/10
C12N 15/87 -
US Classification:800 9, 800 17, 435325, 435455
-
Abstract:Swine animal models comprising a genomic disruption of an endogenous gene chosen from the group consisting of a Low-Density Lipoprotein Receptor gene LDLR, Duchene's Muscular Dystrophy (DMD) gene, and hairless gene (HR). Methods of preparing transfected cells useful for making a transgenic animal comprising exposing a first group of cells to a transfection agent and reseeding the group with additional cells that have not been exposed to the agent. The transgenic animals are useful for medical and scientific animal models of human diseases and conditions, as well as sources for cells, tissues, and biomaterials.
Resumes
Ceo And Chairman At Recombinetics, Inc.
view sourcePosition:
CEO and Chairman of the Board at Recombinetics, Inc., Co-founder and Board Member at Miinome, Inc., Associate Professor at University of Minnesota
Location:
Greater Minneapolis-St. Paul Area
Industry:
Biotechnology
Work:
Recombinetics, Inc. since Sep 2008
CEO and Chairman of the Board
Miinome, Inc. - Greater Minneapolis-St. Paul Area since Jul 2012
Co-founder and Board Member
University of Minnesota since Apr 2001
Associate Professor
Spring Point Project 2003 - 2007
Founder and Chief Scientific Officer
USDA-ARS 1997 - 2001
Geneticist
CEO and Chairman of the Board
Miinome, Inc. - Greater Minneapolis-St. Paul Area since Jul 2012
Co-founder and Board Member
University of Minnesota since Apr 2001
Associate Professor
Spring Point Project 2003 - 2007
Founder and Chief Scientific Officer
USDA-ARS 1997 - 2001
Geneticist
Education:
University of Minnesota-Twin Cities 1991 - 1996
Ph.D., Molecular, Cellular, Developmental Biology and Genetics University of Minnesota-Twin Cities 1986 - 1991
B.S., Genetics & Cell Biology, Microbiology
Ph.D., Molecular, Cellular, Developmental Biology and Genetics University of Minnesota-Twin Cities 1986 - 1991
B.S., Genetics & Cell Biology, Microbiology
Associate Professor At University Of Minnesota
view sourcePosition:
Associate Professor at University of Minnesota
Location:
Greater Minneapolis-St. Paul Area
Industry:
Biotechnology
Work:
University of Minnesota
Associate Professor
USDA-ARS 1997 - 2001
Scientist
University System of Maryland 1996 - 1997
Postdoctoral Researcher
Associate Professor
USDA-ARS 1997 - 2001
Scientist
University System of Maryland 1996 - 1997
Postdoctoral Researcher
Education:
University of Minnesota-Twin Cities 1991 - 1995
Ph.D., Molecular, Cellular, Developmental Biology and Genetics
Ph.D., Molecular, Cellular, Developmental Biology and Genetics
Associate Professor At University Of Minnesota
view sourcePosition:
Associate Professor at University of Minnesota
Location:
Greater Minneapolis-St. Paul Area
Industry:
Biotechnology
Work:
University of Minnesota
Associate Professor
Associate Professor
Education:
University of Minnesota-Twin Cities
Name / Title
Company / Classification
Phones & Addresses
Chief Executive Officer
Recombinetics, Inc
Mfg Misc Products · Mfg Surgical/Medical Instruments
Mfg Misc Products · Mfg Surgical/Medical Instruments
2575 University Ave W, Saint Paul, MN 55114
1246 University Ave W, Saint Paul, MN 55104
2751 Hayes St NE, Minneapolis, MN 55418
6127272000
1246 University Ave W, Saint Paul, MN 55104
2751 Hayes St NE, Minneapolis, MN 55418
6127272000
Youtube
News
Engineered salmon may be a tough sell
view source- would not have to be removed during slaughter, an efficiency for meatpackers. Recombinetics CEO Scott Fahrenkrug says the project is in a holding pattern as investors eye the lengthy salmon approval process, but he says technologies like his will be necessary as global population is set to increase.
- Date: Apr 03, 2014
- Category: Business
- Source: Google
Mylife
Scott Fahrenkrug
view sourceLocality:
Minneapolis, MN
Scott Fahrenkrug
view source
Scott Fahrenkrug
view sourceGoogleplus
Scott Fahrenkrug
Work:
University of Minnesota - Associate Professor (2001)
Recombinetics - CEO (2008)
Recombinetics - CEO (2008)
Education:
University of Minnesota - Genetics
Tagline:
Genome Editor
Get Report for Scott Christopher Fahrenkrug from Minneapolis, MN, age ~61